Home

Provoz možný Hlavní sídlo Typicky puma biotech znásilnění veledílo Plískanice

Puma Biotechnology Inc
Puma Biotechnology Inc

Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma  Biotechnology - Crunchbase Person Profile
Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile

Puma Biotechnology
Puma Biotechnology

Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet

Puma Biotech's Breast Cancer Drug Results Mint New Billionaire Overnight
Puma Biotech's Breast Cancer Drug Results Mint New Billionaire Overnight

Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why

The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha

Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. |  LinkedIn
Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. | LinkedIn

Puma Biotechnology
Puma Biotechnology

Articles about Puma Biotechnology | page 6
Articles about Puma Biotechnology | page 6

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  citybiz
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz

Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors  think so | Fierce Pharma
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma

Puma Biotechnology
Puma Biotechnology

Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in  China - Los Angeles Business Journal
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal

Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect  (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha

SEC charges former Puma biotech exec with $1.1 million in insider trading
SEC charges former Puma biotech exec with $1.1 million in insider trading

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) |  Seeking Alpha
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha

Puma Biotech Rebranding — Alex Maurer Designs
Puma Biotech Rebranding — Alex Maurer Designs

Puma Biotechnology
Puma Biotechnology

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On  Breast & Lung Cancer
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer

Puma Biotechnology
Puma Biotechnology

Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet

Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. |  LinkedIn
Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn

Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology - Crunchbase Company Profile & Funding

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire

Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's  Advisory Panel Vote - TheStreet
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet